Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM. AMG 837 calcium hydrate also shows highly selective over GPR41, GPR43, and GPR120 (EC50 < 10,000 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 36.00 | |
2 mg | In stock | $ 51.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 122.00 | |
25 mg | In stock | $ 257.00 | |
50 mg | In stock | $ 513.00 | |
100 mg | In stock | $ 729.00 | |
200 mg | In stock | $ 995.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 89.00 |
Description | AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM. AMG 837 calcium hydrate also shows highly selective over GPR41, GPR43, and GPR120 (EC50 > 10,000 nM). |
Targets&IC50 | FFA1/GPR40:13 nM (EC50) |
In vitro | GPR40 agonist AMG 837 displayed the expected two-fold increase in potency on GPR4 (EC50: 13 nM) compared to the racemic compound and its activity crossed over to the rat and mouse forms of GPR40 (EC50s: 23/13 nM). AMG 837 was a partial agonist on GPR40 with maximal activity 85% of that shown by DHA. An external panel of 64 receptors also revealed no significant activity with the exception of weak inhibition (IC50: 3 μM) on the α2-adrenergic receptor [1]. |
In vivo | In rats, AMG 837 increases insulin release when glucose levels are elevated [2]. |
Molecular Weight | 950.97 |
Formula | C52H44CaF6O8 |
CAS No. | 1259389-38-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (87.83 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AMG 837 calcium hydrate 1259389-38-2 Endocrinology/Hormones GPCR/G Protein GPR AMG 837 calcium FFAR AMG 837 calcium Hydrate insulin FFA1 Inhibitor Free Fatty Acid Receptor inhibit glucose GPR40 inhibitor